Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel rearrangement method for high-purity pharmaceutical intermediates ensuring cost reduction and supply chain reliability via patent CN108409602A.
Patent CN110483476B reveals a mild Ag2O-catalyzed route for benzoselenophene. Achieve high purity and cost reduction in electronic chemical manufacturing with scalable methods.
Advanced Lewis acid-catalyzed synthesis of Ezetimibe intermediates offers high purity and mild conditions, ensuring cost-effective supply for cardiovascular drug manufacturing.
Novel copper-catalyzed route for 2-azabicyclo[3.2.0] intermediates offers mild conditions and high yields, ensuring reliable supply chain solutions.
Patent CN114085146A reveals a metal-free method for high-yield substituted acrylate synthesis, offering significant cost reduction in API manufacturing and improved supply chain reliability.
Patent CN104152525A reveals dynamic kinetic resolution for R-1-phenylethylamine. Achieve high yield and purity with cost-effective Raney nickel catalysts for supply chain stability.
Patent CN113201516A details a novel P-nitrobenzyl esterase mutant for solvent-free L-menthol production, offering superior stereoselectivity and cost-effective manufacturing.
Patent CN105384809B reveals a segment solid-liquid method improving purity and reducing steps for Teriparatide manufacturing, offering supply chain stability.
Patent CN110759957B reveals a novel KOH-catalyzed route for lipid-soluble isoguanosine intermediates, enhancing bioavailability and reducing purification costs for antisense therapies.
Patent CN1036712C discloses an efficient route for carbocyclic purine antiviral agents. This report analyzes the cost-effective salt-mediated alkylation process for pharmaceutical manufacturing.
Patent CN113748125A details a robust solid-phase method for Liraglutide and Semaglutide. Discover cost-effective manufacturing and high-purity supply chain solutions.
Patent CN107793351B details a novel Pd-catalyzed route to diverse beta-amino acids, offering mild conditions and structural variety for API intermediate manufacturing.
Novel photocatalytic route offers high purity and green manufacturing advantages for pharmaceutical intermediates supply chains globally.
Patent CN103709164A details a cost-effective adenine synthesis using malononitrile, offering high purity and reduced waste for pharmaceutical manufacturing.
Patent CN104350036B details high-yield oxidation for vitamin intermediates. Transition metal catalysis ensures supply chain reliability and cost efficiency for global buyers.
Patent CN105566260A reveals a high yield Furosemide synthesis route offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers seeking reliable API partners.
Patent CN104726513B details high-yield enzymatic Levodopa production. Offers cost reduction in pharmaceutical manufacturing and scalable supply chain solutions for global buyers.
Novel synthetic method for Biotin key intermediate reduces cost and complexity. Reliable supply chain partner for pharmaceutical manufacturing ensuring high purity and scalability.
Patent CN103058998B details a novel AMD3465 synthesis route eliminating column chromatography. This report analyzes cost reduction in pharmaceutical manufacturing and supply chain reliability for high-purity intermediates.
Patent CN102399139B details a scalable resolution method for Shikonin and Alkannin. Achieve >99% ee with cost-effective raw materials for API manufacturing.